Literature DB >> 9127144

Conformation and surface expression of free HLA-CW1 heavy chains in the absence of beta 2-microglobulin.

A Martayan1, M Fiscella, A Setini, G Ciccarelli, R Gambari, G Feriotto, A Beretta, A G Siccardi, E Appella, P Giacomini.   

Abstract

A beta 2-microglobulin (beta 2m)-deficient kidney carcinoma cell line and three monoclonal antibodies to the alpha 1 (L31), alpha 2 (W6/32), and alpha 3 (Q1/28) domain of class I HLA molecules were selected to assess the role of beta 2m in regulating the conformation and surface expression of HLA-C molecules. HLA-A2, -B27, and -CW1 molecules synthesized by beta 2m-deficient cells were compared to heavy chains synthesized in transfectants expressing a large excess of beta 2m. As assessed by differential binding with monoclonal antibodies and partitioning studies in the detergent TX-114, no HLA-A2, -B27, or -CW1 molecules can be expressed, in a correct conformation, by beta 2m-deficient cells. These cells, however, do express low but significant amounts of free HLA-CW1 heavy chains at the cell surface. Transfection with beta 2m causes a coordinate change in the antibody reactivity of the three domains of HLA-CW1 molecules, thereby providing the first experimental demonstration that assembly with beta 2m affects the folding of not only the alpha 1 and alpha 2, but also of the alpha 3 domain. HLA-CW1 heavy chains, when free of beta 2m, are less soluble in the detergent TX-114 than free HLA-B27 heavy chains, and when associated with beta 2m share an alpha 3 domain epitope with free HLA-A2 and -B27 heavy chains. Moreover, their assembly with beta 2m is largely incomplete. Those data additionally demonstrate an impaired ability of HLA-CW1 to properly fold and establish a close similarity of HLA-CW1 to murine Db and Ld molecules. Although the functional role, if any, of free HLA-CW1 heavy chains remains to be determined, the present study demonstrates that the absence of beta 2m does not completely ablate class I expression in neoplastic cells of human origin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9127144     DOI: 10.1016/S0198-8859(96)00256-X

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  9 in total

Review 1.  Interactions of the Immune System with Skin and Bone Tissue in Psoriatic Arthritis: A Comprehensive Review.

Authors:  Andrea Sukhov; Iannis E Adamopoulos; Emanual Maverakis
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

2.  Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells.

Authors:  Elisa Lo Monaco; Elisa Tremante; Cristina Cerboni; Elisa Melucci; Leonardo Sibilio; Alessandra Zingoni; Maria Rita Nicotra; Pier Giorgio Natali; Patrizio Giacomini
Journal:  Neoplasia       Date:  2011-09       Impact factor: 5.715

3.  Conformational maturation and post-ER multisubunit assembly of gap junction proteins.

Authors:  Judy K Vanslyke; Christian C Naus; Linda S Musil
Journal:  Mol Biol Cell       Date:  2009-03-18       Impact factor: 4.138

4.  Conformation of human leucocyte antigen-C molecules at the surface of human trophoblast cells.

Authors:  Richard Apps; Lucy Gardner; Sue E Hiby; Andrew M Sharkey; Ashley Moffett
Journal:  Immunology       Date:  2008-01-18       Impact factor: 7.397

5.  Biosynthesis of HLA-C heavy chains in melanoma cells with multiple defects in the expression of HLA-A, -B, -C molecules.

Authors:  A Martayan; R Fraioli; E Giorda; A Setini; G Ciccarelli; L Delfino; G B Ferrara; P Giacomini
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

Review 6.  HLA-C: An Accomplice in Rheumatic Diseases.

Authors:  Ruby J Siegel; S Louis Bridges; Salahuddin Ahmed
Journal:  ACR Open Rheumatol       Date:  2019-09-06

Review 7.  Four Faces of Cell-Surface HLA Class-I: Their Antigenic and Immunogenic Divergence Generating Novel Targets for Vaccines.

Authors:  Mepur H Ravindranath; Narendranath M Ravindranath; Senthamil R Selvan; Edward J Filippone; Carly J Amato-Menker; Fatiha El Hilali
Journal:  Vaccines (Basel)       Date:  2022-02-21

Review 8.  Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis.

Authors:  Mepur H Ravindranath; Fatiha El Hilali; Carly J Amato-Menker; Hajar El Hilali; Senthamil R Selvan; Edward J Filippone
Journal:  Antibodies (Basel)       Date:  2022-09-08

9.  Ramifications of the HLA-I Allelic Reactivity of Anti-HLA-E*01:01 and Anti-HLA-E*01:03 Heavy Chain Monoclonal Antibodies in Comparison with Anti-HLA-I IgG Reactivity in Non-Alloimmunized Males, Melanoma-Vaccine Recipients, and End-Stage Renal Disease Patients.

Authors:  Mepur H Ravindranath; Narendranath M Ravindranath; Fatiha El Hilali; Senthamil R Selvan; Edward J Filippone
Journal:  Antibodies (Basel)       Date:  2022-03-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.